National HIV Testing Day — June 27, 2015
National HIV Testing Day, June 27, promotes the importance of testing in detecting, treating, and preventing human immunodeficiency virus (HIV) infection. HIV testing is the essential entry point to a continuum of prevention, health care, and social services that improve the quality of life and the length of survival for persons with HIV (1). Recent findings show significantly greater health benefits for persons who start antiretroviral therapy (ART) earlier (2). Persons with HIV who receive appropriate treatment, monitoring, and health care also reduce their chances of transmitting HIV to others (3). The key to HIV treatment, care, and prevention is learning one's status through testing.
In 2011, an estimated 1.2 million persons were living with HIV infection in the United States; an estimated 86% were diagnosed with HIV, 40% were engaged in HIV medical care, 37% were prescribed ART, and 30% achieved viral suppression (1). This issue of MMWR includes a report presenting estimates of the prevalence of diagnosed and undiagnosed HIV infections by state during 2008–2012.
Additional information on National HIV Testing Day is available at http://www.cdc.gov/features/HIVtesting. Basic testing information for consumers is available at http://www.cdc.gov/hiv/basics/testing.html.
Additional information on HIV testing for health professionals is available at http://www.cdc.gov/hiv/testing. CDC's guidelines for HIV testing of serum and plasma specimens are available at http://www.cdc.gov/hiv/testing/laboratorytests.html.
References
- Bradley H, Hall HI, Wolitski RJ, et al. Vital signs: HIV diagnosis, care, and treatment among persons living with HIV—United States, 2011. MMWR Morb Mortal Wkly Rep 2014;63:1113–7.
- National Institute of Allergy and Infectious Diseases. Starting antiretroviral treatment early improves outcomes for HIV-infected individuals. Available at http://www.niaid.nih.gov/news/newsreleases/2015/Pages/START.aspx.
- Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365:493–505.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.
References to non-CDC sites on the Internet are
provided as a service to MMWR readers and do not constitute or imply
endorsement of these organizations or their programs by CDC or the U.S.
Department of Health and Human Services. CDC is not responsible for the content
of pages found at these sites. URL addresses listed in MMWR were current as of
the date of publication.
All MMWR HTML versions of articles are electronic conversions from typeset documents.
This conversion might result in character translation or format errors in the HTML version.
Users are referred to the electronic PDF version (http://www.cdc.gov/mmwr)
and/or the original MMWR paper copy for printable versions of official text, figures, and tables.
An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S.
Government Printing Office (GPO), Washington, DC 20402-9371;
telephone: (202) 512-1800. Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to
mmwrq@cdc.gov.